Shiho Nakamura
Overview
Explore the profile of Shiho Nakamura including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
275
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Setsu S, Morimoto S, Nakamura S, Ozawa F, Utami K, Nishiyama A, et al.
Stem Cell Reports
. 2024 Dec;
20(1):102377.
PMID: 39706179
This study introduces a novel method for rapidly and efficiently inducing human spinal lower motor neurons (LMNs) from induced pluripotent stem cells (iPSCs) to eventually elucidate the pathomechanisms of amyotrophic...
2.
Mandai K, Nakamura S
Cureus
. 2024 Sep;
16(8):e66983.
PMID: 39280535
We present the case of an 82-year-old female with obstructive jaundice secondary to a malignant distal biliary stricture. Endoscopic ultrasound-guided hepaticogastrostomy (EUS-HGS) was performed. The presence of a giant hiatal...
3.
Nakamura S, Inoue N, Uno K
Gastro Hep Adv
. 2024 Aug;
3(5):587-588.
PMID: 39165426
No abstract available.
4.
Kato C, Ueda K, Morimoto S, Takahashi S, Nakamura S, Ozawa F, et al.
Inflamm Regen
. 2024 Jul;
44(1):32.
PMID: 38997748
Background: Extracellular vesicles (EVs) hold the potential for elucidating the pathogenesis of amyotrophic lateral sclerosis (ALS) and serve as biomarkers. Notably, the comparative and longitudinal alterations in the protein profiles...
5.
Leventoux N, Morimoto S, Ishikawa M, Nakamura S, Ozawa F, Kobayashi R, et al.
Acta Neuropathol
. 2024 May;
147(1):84.
PMID: 38750212
Amyotrophic Lateral Sclerosis/Parkinsonism-Dementia Complex (ALS/PDC), a rare and complex neurological disorder, is predominantly observed in the Western Pacific islands, including regions of Japan, Guam, and Papua. This enigmatic condition continues...
6.
7.
Phase 1/2a clinical trial in ALS with ropinirole, a drug candidate identified by iPSC drug discovery
Morimoto S, Takahashi S, Ito D, Date Y, Okada K, Kato C, et al.
Cell Stem Cell
. 2023 Jun;
30(6):766-780.e9.
PMID: 37267913
iPSC-based drug discovery led to a phase 1/2a trial of ropinirole in ALS. 20 participants with sporadic ALS received ropinirole or placebo for 24 weeks in the double-blind period to...
8.
Nakamura R, Tohnai G, Nakatochi M, Atsuta N, Watanabe H, Ito D, et al.
J Neurol Neurosurg Psychiatry
. 2023 May;
94(10):816-824.
PMID: 37142397
Background: Several genetic factors are associated with the pathogenesis of sporadic amyotrophic lateral sclerosis (ALS) and its phenotypes, such as disease progression. Here, in this study, we aimed to identify...
9.
Mandai K, Kanemitsu Y, Nakamura S
Endoscopy
. 2023 Apr;
55(S 01):E682-E683.
PMID: 37100408
No abstract available.
10.
Qian E, Uemura M, Kobayashi H, Nakamura S, Ozawa F, Yoshimatsu S, et al.
Inflamm Regen
. 2023 Apr;
43(1):23.
PMID: 37009886
Cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy (CARASIL) is an inherited cerebral small vessel disease (CSVD) caused by biallelic mutations in the high-temperature requirement serine peptidase A1 (HTRA1)...